These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 19148905

  • 1. The insulin-like growth factor system and sarcomas.
    Rikhof B, de Jong S, Suurmeijer AJ, Meijer C, van der Graaf WT.
    J Pathol; 2009 Mar; 217(4):469-82. PubMed ID: 19148905
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
    Friedrichs N, Küchler J, Endl E, Koch A, Czerwitzki J, Wurst P, Metzger D, Schulte JH, Holst MI, Heukamp LC, Larsson O, Tanaka S, Kawai A, Wardelmann E, Buettner R, Pietsch T, Hartmann W.
    J Pathol; 2008 Dec; 216(4):428-39. PubMed ID: 18855347
    [Abstract] [Full Text] [Related]

  • 3. Targeting IGF-1R in the treatment of sarcomas: past, present and future.
    Kim SY, Wan X, Helman LJ.
    Bull Cancer; 2009 Dec; 96(7):E52-60. PubMed ID: 19617179
    [Abstract] [Full Text] [Related]

  • 4. Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors.
    Scotlandi K, Manara MC, Nicoletti G, Lollini PL, Lukas S, Benini S, Croci S, Perdichizzi S, Zambelli D, Serra M, García-Echeverría C, Hofmann F, Picci P.
    Cancer Res; 2005 May 01; 65(9):3868-76. PubMed ID: 15867386
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling.
    Garofalo C, Manara MC, Nicoletti G, Marino MT, Lollini PL, Astolfi A, Pandini G, López-Guerrero JA, Schaefer KL, Belfiore A, Picci P, Scotlandi K.
    Oncogene; 2011 Jun 16; 30(24):2730-40. PubMed ID: 21278796
    [Abstract] [Full Text] [Related]

  • 6. Targeting insulin-like growth factor 1 receptor in sarcomas.
    Scotlandi K, Picci P.
    Curr Opin Oncol; 2008 Jul 16; 20(4):419-27. PubMed ID: 18525338
    [Abstract] [Full Text] [Related]

  • 7. The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers.
    Camidge DR, Dziadziuszko R, Hirsch FR.
    Clin Lung Cancer; 2009 Jul 16; 10(4):262-72. PubMed ID: 19632946
    [Abstract] [Full Text] [Related]

  • 8. Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedside.
    Olmos D, Tan DS, Jones RL, Judson IR.
    Cancer J; 2010 Jul 16; 16(3):183-94. PubMed ID: 20526094
    [Abstract] [Full Text] [Related]

  • 9. Preclinical in vivo study of new insulin-like growth factor-I receptor--specific inhibitor in Ewing's sarcoma.
    Manara MC, Landuzzi L, Nanni P, Nicoletti G, Zambelli D, Lollini PL, Nanni C, Hofmann F, García-Echeverría C, Picci P, Scotlandi K.
    Clin Cancer Res; 2007 Feb 15; 13(4):1322-30. PubMed ID: 17317844
    [Abstract] [Full Text] [Related]

  • 10. [Roles of insulin-like growth factor system in colorectal carcinoma and its applications].
    Yang X, Wan DS.
    Ai Zheng; 2005 Sep 15; 24(9):1161-4. PubMed ID: 16159447
    [Abstract] [Full Text] [Related]

  • 11. The IGF system in in-vitro human decidualization.
    Ganeff C, Chatel G, Munaut C, Frankenne F, Foidart JM, Winkler R.
    Mol Hum Reprod; 2009 Jan 15; 15(1):27-38. PubMed ID: 19038974
    [Abstract] [Full Text] [Related]

  • 12. The insulin-like growth factor system.
    Le Roith D.
    Exp Diabesity Res; 2003 Jan 15; 4(4):205-12. PubMed ID: 14668044
    [Abstract] [Full Text] [Related]

  • 13. Insulin-like growth factors and pancreas beta cells.
    van Haeften TW, Twickler TB.
    Eur J Clin Invest; 2004 Apr 15; 34(4):249-55. PubMed ID: 15086355
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor ligands, receptors, and binding proteins in cancer.
    Foulstone E, Prince S, Zaccheo O, Burns JL, Harper J, Jacobs C, Church D, Hassan AB.
    J Pathol; 2005 Jan 15; 205(2):145-53. PubMed ID: 15641016
    [Abstract] [Full Text] [Related]

  • 15. The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer.
    Ryan PD, Goss PE.
    Oncologist; 2008 Jan 15; 13(1):16-24. PubMed ID: 18245009
    [Abstract] [Full Text] [Related]

  • 16. Role of IGFs and insulin in the human testis during postnatal activation: differentiation of steroidogenic cells.
    Berensztein EB, Baquedano MS, Pepe CM, Costanzo M, Saraco NI, Ponzio R, Rivarola MA, Belgorosky A.
    Pediatr Res; 2008 Jun 15; 63(6):662-6. PubMed ID: 18520331
    [Abstract] [Full Text] [Related]

  • 17. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
    Avnet S, Sciacca L, Salerno M, Gancitano G, Cassarino MF, Longhi A, Zakikhani M, Carboni JM, Gottardis M, Giunti A, Pollak M, Vigneri R, Baldini N.
    Cancer Res; 2009 Mar 15; 69(6):2443-52. PubMed ID: 19258511
    [Abstract] [Full Text] [Related]

  • 18. Reduced growth of human sarcoma xenografts in hosts homozygous for the lit mutation.
    Deitel K, Dantzer D, Ferguson P, Pollak M, Beamer W, Andrulis I, Bell R.
    J Surg Oncol; 2002 Oct 15; 81(2):75-9. PubMed ID: 12355407
    [Abstract] [Full Text] [Related]

  • 19. Molecular interactions of the IGF system.
    Denley A, Cosgrove LJ, Booker GW, Wallace JC, Forbes BE.
    Cytokine Growth Factor Rev; 2005 Oct 15; 16(4-5):421-39. PubMed ID: 15936977
    [Abstract] [Full Text] [Related]

  • 20. The IGF axis and placental function. a mini review.
    Forbes K, Westwood M.
    Horm Res; 2008 Oct 15; 69(3):129-37. PubMed ID: 18219215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.